Two companies have received approved for a generic of the 2.5 mg tablet of anticoagulant rivaroxaban, which is used to reduce ...

The U.S. Food and Drug Administration (FDA) has released several important updates addressing new medication approvals and ...

Bayer and Janssen’s novel oral anticoagulant (NOAC) Xarelto has a new string to its bow after the FDA approved it to prevent blood clots in acutely ill medical patients. The drug, marketed by ...

We are the problem when we would rather take the injection or the pill than make the lifestyle change. I am fortunate that I ...

Lupin is introducing rivaroxaban tablets, 2.5 mg, which is the generic of Janssen’s Xarelto.

Janssen Pharms' Xarelto is prescribed to reduce the risk ... for months after the CMS selected 10 high-priced, single-source drugs that didn't have generic or competitor versions to renegotiate ...

Those drugs were Eliquis, Jardiance, Xarelto, Januvia, Farxiga, Entresto, Enbrel, Imbruvica, Stelara and Fiasp/NovoLog. CMS is following a certain set of parameters to determine which drugs are ...

Late last week, J&J said that the new approach for Xarelto and Stelara – both drugs subject to the first round of Medicare negotiations under the Inflation Reduction Act (IRA) with prices ...

Citi said the company's announcement of generic Rivaroxaban 2.5 mg (Xarelto 2.5mg) tablets in the US is an "at risk" launch ...

The Food and Drug Administration (FDA) has approved the first generics of Xarelto ® (rivaroxaban) 2.5mg. Xarelto 2.5mg is used, in combination with aspirin, to: Reduce the risk of major cardiovascular ...

The approval is only for the 2.5mg tablet. The Food and Drug Administration (FDA) has approved the first generics of Xarelto ® (rivaroxaban) 2.5mg. Xarelto 2.5mg is used, in combination with ...